Parkinson's

Simple blood test for Parkinson's on the horizon

In what can be termed as major breakthrough in biomarker research, a simple blood test for an early diagnosis of the “age-related disorder”, Parkinson’s, may be on its way.

Researchers from the United Kingdom have developed a blood test to detect Parkinson’s in the early stages, well before external symptoms emerge, which could pave the way for a more effective treatment

Ibuprofen may protect against Parkinson's disease--study

As per a latest study published online in the journal 'Neurology,' regular use of over-the-counter pain reliever ibuprofen can cut the risk of developing Parkinson's disease by more than a third and even slow down progression of the disease.

pills2x-large.jpg

Researchers at the Harvard University claim that taking ibuprofen just two or three times a week can reduce the risk of developing Parkinson's disease by 38 percent.

Xiang Gao, MD, PhD, with Harvard School of Public Health, Brigham and Women's Hospital and Harvard Medical School in Boston, said in a press release: "Our results show that ibuprofen may protect the brain in ways that other nonsteroidal anti-inflammatory drugs (NSAIDS) and analgesics, such as aspirin or acetaminophen, cannot.”

Blood test to detect Alzheimer's in early stages

As per a new study published in the Jan. 7 issue of the journal 'Cell,' a blood test to detect biomarkers or antibodies produced by the immune system at the onset of an ailment can be used to detect Alzheimer's in its early stages.

blood-test_2.jpg

Approximately 5 million Americans are affected by Alzheimer's, according to the American government and there is still no cure for this deadly disease. At this point of time, even if it is detected early, it can’t be helped.

US researchers have found a way to harness the immune system to detect Alzheimer’s. They believe this approach can lead to the discovery of a blood test for the detection of the disease within months.

Details of the study

Syndicate content